Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5014478 | 0.92 | CNR2 (0.44) | CNR2CNR1 | |
| SCHEMBL8961230 | 0.90 | CNR2 (0.48) | CNR2CNR1 | |
| SCHEMBL8961128 | 0.89 | CNR2 (0.45) | CNR2CNR1 | |
| SCHEMBL11299089 | 0.80 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL1291247 | 0.77 | GABRA1 (0.34) | — | |
| SCHEMBL7060581 | 0.76 | CNR2 (0.48) | CNR2CNR1 | |
| SCHEMBL8961177 | 0.75 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL3693245 | 0.74 | PTGS2 (0.44) | — | |
| SCHEMBL5670470 | 0.73 | CNR2 (0.55) | CNR2CNR1 | |
| SCHEMBL8961315 | 0.73 | CNR2 (0.44) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484334-A2 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-08 | — | — | EP | disclosed |
| US-20040225145-A1 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-11-11 | — | — | US | disclosed |
| US-5889095-A | OXYGEN AND HEAT RESISTANCE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040225145-A1 | Process for producing phosphite | PHOSPHO1, PLCG1, PLCG2 | CNR2 1787/4885CNR1 1365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.